Skip to content
★ Sign in to follow
EM

Elizabeth M. Keiley

Board Director
Conseillère Juridique
Entasis Therapeutics Holdings Inc.Oxford Immunotec Global PLC
Total declarations
21
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€171k

Latest filing published 11 Jul 2022 for Entasis Therapeutics Holdings Inc..

Filing timeline

BuySale
Elizabeth M. Keiley

Insider track record

Disclosed buys
0
Disclosed sells
4
Signal history

Elizabeth M. Keiley: trading record in brief

Elizabeth M. Keiley is a declared insider at 2 companies (board member); the most frequent names are Oxford Immunotec Global PLC and Entasis Therapeutics Holdings Inc. We count 21 filings; the first trade dates from 9 June 2015 and the latest from 11 July 2022.

The open-market record consists of 4 sales worth €171k, with no purchase. The rest of the record consists of 13 share grants and 2 option exercises.

On 11 July 2022 came the latest disclosure, a transaction in Entasis Therapeutics Holdings Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Elizabeth M. Keiley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total

21 of 20 declarations